1922GCCC: Pembro and Bavituximab for Squamous Cell Carcinoma of Head and Neck

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
1922GCCC: Pembro and Bavituximab for Squamous Cell Carcinoma of Head and Neck	Neoplasms by Histologic Type, carcinoma, epithelial neoplasm, neoplasm, squamous cell carcinoma, squamous cell neoplasm	Active, not recruiting	Phase 2	2026-02-19		NCT04150900

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
University of Maryland, Baltimore	198

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
University of Maryland Medical Center	Baltimore	United States	87

Clinical trials